Literature DB >> 24614609

Age-based difference in activation markers of coagulation and fibrinolysis in extracorporeal membrane oxygenation.

Shilpa G Hundalani1, Kim T Nguyen, Esther Soundar, Vadim Kostousov, Lisa Bomgaars, Alicia Moise, Shiu-Ki R Hui, Jun Teruya.   

Abstract

OBJECTIVE: Coagulation system activation in extracorporeal membrane oxygenation results in hemostatic derangements. Thrombin generation markers like prothrombin fragment 1+2 and thrombin-antithrombin complex are sensitive markers of hypercoagulability. Plasmin-antiplasmin complex is a sensitive marker for fibrinolysis. D-dimers reflect thrombin generation and fibrinolysis. The aim was to identify the extent of hemostasis activation during extracorporeal membrane oxygenation by measuring thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer.
DESIGN: Prospective cohort study.
SETTING: Tertiary care academic center. PATIENTS: Children placed on extracorporeal membrane oxygenation from April 2011 to January 2013.
INTERVENTIONS: Prothrombin fragment 1+2, thrombin-antithrombin complex, plasmin-antiplasmin complex, and D-dimer were measured on days 1 and 5 of extracorporeal membrane oxygenation.
MEASUREMENTS AND MAIN RESULTS: Data presented as median (interquartile range); nonparametric tests were done using SPSS. Twenty-nine children (52% < 30 d old [neonates], median extracorporeal membrane oxygenation length 151 hr) were studied. Complications included thrombosis in 14%, bleeding in 45%, and thrombosis and bleeding together in 10%. Thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer levels were high on day 1 and remained increased on extracorporeal membrane oxygenation. In neonates, all levels were higher on day 5 compared with day 1: thrombin-antithrombin complex (55.6 μg/L [30.7-76.0] vs 18.7 μg/L [10.9-34.6]; p = 0.03), prothrombin fragment 1+2 (2,038 pmol/L [1,093-4,018.5] vs 377.5 pmol/L [334.3-1,103.0]; p = 0.00), plasmin-antiplasmin complex (2,160 μg/L [786-3,090] vs 398 μg/L [296.8-990.8]; p = 0.00), and D-dimer (3.0 μg/mL [1.9-11.5] vs 1.5 μg/mL [0.6-2.9]; p = 0.01). Thrombin-antithrombin complex, prothrombin fragment 1+2, plasmin-antiplasmin complex, and D-dimer levels did not correlate with anti-Xa activity or heparin dose. In bleeders older than 30 days, plasmin-antiplasmin complex stayed elevated on day 5, but in patients with no bleeding complications, plasmin-antiplasmin level showed a declining trend. In neonates, plasmin-antiplasmin levels increased over the course of extracorporeal membrane oxygenation irrespective of bleeding.
CONCLUSION: Despite our best efforts at adequate anticoagulation with unfractionated heparin, neonates showed persistent increase in coagulation activation on extracorporeal membrane oxygenation. Fibrinolysis activation may contribute to bleeding in patients older than 30 days. Different anticoagulation protocols should be individualized based on age.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24614609     DOI: 10.1097/PCC.0000000000000107

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  9 in total

1.  The Heparin-Antithrombin Product: A Novel Value for Pediatric Extracorporeal Anticoagulation.

Authors:  Colin M Rogerson; Michael J Hobson
Journal:  J Extra Corpor Technol       Date:  2022-06

2.  Use of Thromboelastography to Predict Thrombotic Complications in Pediatric and Neonatal Extracorporeal Membranous Oxygenation.

Authors:  Natalie Henderson; Janice E Sullivan; John Myers; Terri Wells; Aaron Calhoun; John Berkenbosch; Deanna Todd Tzanetos
Journal:  J Extra Corpor Technol       Date:  2018-09

Review 3.  Anticoagulation in Neonatal ECMO: An Enigma Despite a Lot of Effort!

Authors:  Katherine Cashen; Kathleen Meert; Heidi Dalton
Journal:  Front Pediatr       Date:  2019-09-13       Impact factor: 3.418

4.  The Developing Balance of Thrombosis and Hemorrhage in Pediatric Surgery: Clinical Implications of Age-Related Changes in Hemostasis.

Authors:  Meredith A Achey; Uttara P Nag; Victoria L Robinson; Christopher R Reed; Gowthami M Arepally; Jerrold H Levy; Elisabeth T Tracy
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

5.  Hemostasis, coagulation and thrombin in venoarterial and venovenous extracorporeal membrane oxygenation: the HECTIC study.

Authors:  Bruce Cartwright; Hannah M Bruce; Geoffrey Kershaw; Nancy Cai; Jad Othman; David Gattas; Jacqueline L Robson; Sarah Hayes; Hayden Alicajic; Anna Hines; Alice Whyte; Nophanan Chaikittisilpa; Timothy James Southwood; Paul Forrest; Richard J Totaro; Paul G Bannon; Scott Dunkley; Vivien M Chen; Mark Dennis
Journal:  Sci Rep       Date:  2021-04-12       Impact factor: 4.379

6.  Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a retrospective study.

Authors:  Lars Heubner; Marvin Greiner; Oliver Vicent; Jan Beyer-Westendorf; Oliver Tiebel; Ute Scholz; Andreas Güldner; Martin Mirus; Dietmar Fries; Thea Koch; Peter Markus Spieth
Journal:  Thromb J       Date:  2022-08-29

Review 7.  Hemostasis in neonatal ECMO.

Authors:  Valeria Cortesi; Genny Raffaeli; Giacomo S Amelio; Ilaria Amodeo; Silvia Gulden; Francesca Manzoni; Gaia Cervellini; Andrea Tomaselli; Marta Colombo; Gabriella Araimo; Andrea Artoni; Stefano Ghirardello; Fabio Mosca; Giacomo Cavallaro
Journal:  Front Pediatr       Date:  2022-08-26       Impact factor: 3.569

Review 8.  ECMO for Neonatal Sepsis in 2019.

Authors:  Warwick Wolf Butt; Roberto Chiletti
Journal:  Front Pediatr       Date:  2020-02-21       Impact factor: 3.418

9.  Anti-Xa versus time-guided anticoagulation strategies in extracorporeal membrane oxygenation: a systematic review and meta-analysis.

Authors:  Ariane Willems; Peter P Roeleveld; Sonia Labarinas; John W Cyrus; Jennifer A Muszynski; Marianne E Nellis; Oliver Karam
Journal:  Perfusion       Date:  2020-08-29       Impact factor: 1.972

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.